Biochem/physiol Actions KL201 is a circadian clock modulator that lengthens a circadian period in cells and tissues. KL201 selectively regulate cryptochrome 1 (Cry1).
Biochem/physiol Actions KL201 is a circadian clock modulator that lengthens a circadian period in cells and tissues. KL201 selectively regulate cryptochrome 1 (Cry1).
Biochem/physiol Actions KL201 is a circadian clock modulator that lengthens a circadian period in cells and tissues. KL201 selectively regulate cryptochrome 1 (Cry1).
Biochem/physiol Actions KL201 is a circadian clock modulator that lengthens a circadian period in cells and tissues. KL201 selectively regulate cryptochrome 1 (Cry1).
General description Human euchromatic histone-lysine N-methyltransferase (EHMT1), also known as G9a-like protein (GLP) or KMT1D, (GenBank Accession No. NM_024757), amino acids 894-1298 (end) with N-terminal GST-tag, MW= 72.
General description Human euchromatic histone-lysine N-methyltransferase (EHMT1), also known as G9a-like protein (GLP) or KMT1D, (GenBank Accession No. NM_024757), amino acids 894-1298 (end) with N-terminal GST-tag, MW= 72.
XL041 (BMS-852927) is an LXRβ -selective agonist.In VitroXL041 (BMS-852927) is an LXRβ-selective agonist with 20% LXRα and 88% LXRβ activity compared to a full pan agonist in transactivation assays. XL041 is potent, with an EC 50 =9 nM and 26%
XL041 (BMS-852927) is an LXRβ -selective agonist.In VitroXL041 (BMS-852927) is an LXRβ-selective agonist with 20% LXRα and 88% LXRβ activity compared to a full pan agonist in transactivation assays. XL041 is potent, with an EC 50 =9 nM and 26%
XL041 (BMS-852927) is an LXRβ -selective agonist.In VitroXL041 (BMS-852927) is an LXRβ-selective agonist with 20% LXRα and 88% LXRβ activity compared to a full pan agonist in transactivation assays. XL041 is potent, with an EC 50 =9 nM and 26%
XL041 (BMS-852927) is an LXRβ -selective agonist.In VitroXL041 (BMS-852927) is an LXRβ-selective agonist with 20% LXRα and 88% LXRβ activity compared to a full pan agonist in transactivation assays. XL041 is potent, with an EC 50 =9 nM and 26%
XL041 (BMS-852927) is an LXRβ -selective agonist.In VitroXL041 (BMS-852927) is an LXRβ-selective agonist with 20% LXRα and 88% LXRβ activity compared to a full pan agonist in transactivation assays. XL041 is potent, with an EC 50 =9 nM and 26%
XL041 (BMS-852927) is an LXRβ -selective agonist.In VitroXL041 (BMS-852927) is an LXRβ-selective agonist with 20% LXRα and 88% LXRβ activity compared to a full pan agonist in transactivation assays. XL041 is potent, with an EC 50 =9 nM and 26%
XL041 (BMS-852927) is an LXRβ -selective agonist.In VitroXL041 (BMS-852927) is an LXRβ-selective agonist with 20% LXRα and 88% LXRβ activity compared to a full pan agonist in transactivation assays. XL041 is potent, with an EC 50 =9 nM and 26%
XL041 (BMS-852927) is an LXRβ -selective agonist.In VitroXL041 (BMS-852927) is an LXRβ-selective agonist with 20% LXRα and 88% LXRβ activity compared to a full pan agonist in transactivation assays. XL041 is potent, with an EC 50 =9 nM and 26%
XL041 (BMS-852927) is an LXRβ -selective agonist.In VitroXL041 (BMS-852927) is an LXRβ-selective agonist with 20% LXRα and 88% LXRβ activity compared to a full pan agonist in transactivation assays. XL041 is potent, with an EC 50 =9 nM and 26%
XL041 (BMS-852927) is an LXRβ -selective agonist.In VitroXL041 (BMS-852927) is an LXRβ-selective agonist with 20% LXRα and 88% LXRβ activity compared to a full pan agonist in transactivation assays. XL041 is potent, with an EC 50 =9 nM and 26%
XL041 (BMS-852927) is an LXRβ -selective agonist.In VitroXL041 (BMS-852927) is an LXRβ-selective agonist with 20% LXRα and 88% LXRβ activity compared to a full pan agonist in transactivation assays. XL041 is potent, with an EC 50 =9 nM and 26%
XL041 (BMS-852927) is an LXRβ -selective agonist.In VitroXL041 (BMS-852927) is an LXRβ-selective agonist with 20% LXRα and 88% LXRβ activity compared to a full pan agonist in transactivation assays. XL041 is potent, with an EC 50 =9 nM and 26%
Application DMOTY TEA is a thiacyanine-based fluorescent autophagy probe that localizes to lysosomes of live cells via selective binding to G-quadruplexes. DMOTY TEA will be a valuable tool for probing autophagy mechanisms and drug discovery
Application DMOTY TEA is a thiacyanine-based fluorescent autophagy probe that localizes to lysosomes of live cells via selective binding to G-quadruplexes. DMOTY TEA will be a valuable tool for probing autophagy mechanisms and drug discovery